Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly. Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading ->
Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading ->
A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading ->
There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading ->
Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading ->
Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading ->
Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading ->
It is “imperative” that governments recognize the long-term effects of COVID-19 and ensure that affected people can access health services, including primary health care as well as rehabilitation, emphasized the World Health Organization on Friday. “Although we are still learning about this virus, what’s clear is that this is not just a virus that kills […] Continue reading ->
University of Basel. Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week in medRixv. While there is no evidence of this variant being more dangerous, its spread may give insights into the efficacy of travel policies […] Continue reading ->
Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading ->